Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study

Kirsten Nørgaard, Andrea Scaramuzza, Natasa Bratina, Nebojsa M Lalić, Przemyslaw Jarosz-Chobot, Győző Kocsis, Edita Jasinskiene, Christophe De Block, Odile Carrette, Javier Castañeda, Ohad Cohen, Interpret Study Group

95 Citations (Scopus)


Sensor-augmented pump (SAP) therapy can improve glycemic control, compared with multiple daily insulin injections or with insulin pump therapy alone, without increasing the risk of hypoglycemia.
Original languageEnglish
JournalDiabetes Technology & Therapeutics
Issue number4
Pages (from-to)273-80
Number of pages8
Publication statusPublished - Apr 2013


  • Adolescent
  • Adult
  • Aged
  • Biosensing Techniques
  • Blood Glucose
  • Body Mass Index
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1
  • Europe
  • Female
  • Hemoglobin A, Glycosylated
  • Hospitalization
  • Humans
  • Hypoglycemic Agents
  • Infant
  • Insulin Infusion Systems
  • Israel
  • Length of Stay
  • Male
  • Middle Aged
  • Prospective Studies
  • Treatment Outcome


Dive into the research topics of 'Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study'. Together they form a unique fingerprint.

Cite this